4-AHP

4-AHP
Clinical data
Other names4-(Aminomethyl)-1-hydroxypyrazole
Drug classGABAA receptor agonist
ATC code
  • None
Identifiers
  • (1-hydroxypyrazol-4-yl)methanamine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC4H7N3O
Molar mass113.120 g·mol−1
3D model (JSmol)
  • C1=C(C=NN1O)CN
  • InChI=1S/C4H7N3O/c5-1-4-2-6-7(8)3-4/h2-3,8H,1,5H2
  • Key:SGFQVPARKZCZOT-UHFFFAOYSA-N

4-AHP, also known as 4-(aminomethyl)-1-hydroxypyrazole, is a synthetic GABAA receptor agonist related to the alkaloid and Amanita muscaria constituent muscimol.

Pharmacology

The drug is a moderately potent and high-efficacy partial to full agonist of the GABAA receptor (RmaxTooltip maximal efficacy = 69–108%). It is less potent as a GABAA receptor agonist than γ-aminobutyric acid (GABA), muscimol, or gaboxadol (THIP) (e.g., ~30-fold lower affinity and ~24-fold lower activational potency than muscimol), but shows a similar functional activity profile relative to those of GABA and muscimol. The drug is also a high-efficacy partial agonist of the GABAA-ρ receptor (~4-fold less potent than muscimol). It does not appear to have been evaluated in animals and its effects are unknown. 4-AHP is a close analogue of muscimol, in which the isoxazole ring has been replaced with a pyrazole ring.

Development

4-AHP was first described in the scientific literature by 2013. It is one of only a few known analogues of muscimol that have been found to act as high-efficacy GABAA receptor agonists, along with other related compounds such as dihydromuscimol, thiomuscimol, and gaboxadol. This can be attributed to the very strict structural requirements for GABAA receptor binding and activation. A number of derivatives of 4-AHP have been synthesized and studied as GABAA receptor ligands.